Silo Pharma, .

Silo Pharma, .
Silo Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for neurological disorders.
About
What does Silo Pharma, . do?
Silo Pharma, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for challenging neurological disorders. The company's pipeline includes drug candidates targeting conditions such as Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases. Silo Pharma aims to leverage its scientific expertise and innovative drug delivery platforms to create treatments that can significantly improve patient outcomes.
Where is Silo Pharma, . headquartered?
Silo Pharma, . is headquartered in Englewood, United States.
What industry does Silo Pharma, . operate in?
Silo Pharma, . operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Neurotech & HCI.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
“Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform.”
View on Reddit“Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules.”
View on Reddit“Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request.”
View on Reddit“Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial.”
View on Reddit“Looking at $SILO Silo Pharma. After scanning for similar companies with fibromyalgia treatments in development, Silo Pharma $SILO came up with recent news on fibromyalgia.”
View on Reddit“SILOphilia. [SILO PHARMA INC.] We are $SILO shareholders and SILOphilia is the place to grow awareness, share knowledge and informations about the scientific studies on psychedelic drugs for the treatment of severe neurological conditions.…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.